Variable | Single-strain infection (n = 7) | Mixed-strain infection (n = 5) | All a (n = 12) |
---|---|---|---|
Age, mean years (SD) | 33.1 (11.2) | 30.4 (6.1) | 32.0 (9.2) |
Gender, Male, number (%) | 5 (71.4) | 4 (80.0) | 9 (75.0) |
P.Phe508del heterozygous, number (%) | 5 (71.4) | 1 (20.0) | 6 (50.0) |
P.Phe508del homozygous, number (%) | 2 (28.6) | 4 (80.0) | 6 (50.0) |
FEV1% predicted, mean (SD) | 45.9 (20.8) | 45.6 (15.3) | 45.8 (17.9) |
BMI, mean kg/m2 (SD) | 23.7 (6.7) | 21.6 (3.3) | 22.9 (5.4) |
Chronic Pseudomonas aeruginosa infection >10-years, number (%) | 6 (85.7) | 5 (100) | 11 (91.7) |
Clinical care in previous year, mean (SD) | |||
Number of hospital admissions | 2.1 (2.0) | 4.8 (2.9) | 3.3 (2.7) |
Number of inpatient days | 29.1 (30.0) | 69.0 (37.1) | 45.8 (37.6) |
Number of outpatient clinic visits | 11.6 (8.7) | 16.2 (3.0) | 13.6 (7.1) |
Regular treatments prescribed in previous year, number (%) | |||
Oral azithromycin | 7 (100) | 5 (100) | 12 (100) |
Inhaled colistin | 3 (42.9) | 3 (60.0) | 6 (50.0) |
Inhaled tobramycin | 6 (85.7) | 4 (80.0) | 10 (83.3) |
Diabetes, number (%) | 1 (14.3) | 1 (20.0) | 2 (16.7) |